Earnings call transcript: Monro Inc. Q3 2024 misses EPS forecast, stock dips
Monro Inc. (MNRO) reported its financial results for the third quarter of fiscal year 2024, revealing a decline in both earnings per share (EPS) and revenue compared to forecasts. The company's EPS ...
XTI Aerospace (XTIA) Receives a New Rating from Maxim Group
Maxim Group analyst Tate Sullivan initiated coverage with a Buy rating on XTI Aerospace (XTIA – Research Report) yesterday and set a price ...
Obesity-drug maker Metsera posts largest gain as IPOs defy market swoon
Oil company Natural Resources and medical-device maker Beta Bionics shrug off a down market to gain in their trading debuts.
Akero raised to Buy at Bank of America after liver drug data
Akero Therapeutics (AKRO) stock was upgraded by Bank of America based on Phase 2 data the company shared for its liver disorder drug, efruxifermin. Read more here.
Maxim Group Reaffirms Their Buy Rating on Icon Energy Corp. (ICON)
Maxim Group analyst Tate Sullivan maintained a Buy rating on Icon Energy Corp. (ICON – Research Report) yesterday. The company’s shares opened ...